GlassScriptPhysician profile
William Isaac Sawyer
NPI 1699969634
$1,971.08
in general payments reported to CMS, 2019-2025
16 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $263 · 2021: $345 · 2022: $396 · 2023: $199 · 2024: $216 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603 · Honoraria: $58.03 · Gift: $36.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.82 |
| Honoraria | $58.03 |
| Gift | $36.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $498.66 | 2019-2025 | Centurion, Clareon, Tryptyr |
| Johnson & Johnson Surgical Vision, INC. | $241.26 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $201.93 | 2019-2025 | Cequa |
| Glaukos Corporation | $147.25 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $142.43 | 2019-2021 | |
| Sight Sciences, INC. | $135.19 | 2024 | Omni Surgical System |
| Ocular Therapeutix, INC. | $126.53 | 2024-2025 | Dextenza |
| Carl Zeiss Meditec, INC. | $98.33 | 2019 | |
| Biotissue Holdings INC. | $70.57 | 2020-2022 | |
| Rxsight INC | $66.15 | 2022-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Allergan, INC. | $51.60 | 2020-2021 | |
| Carl Zeiss Meditec USA, INC. | $49.98 | 2023-2025 | Visumax, Quatera 700 |
| Katena Products, INC. (Dba Corza Medical) | $43.79 | 2019 | |
| Omeros Corporation | $34.53 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $34.23 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $28.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sawyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.